For the Inventor, By the Inventor

Enter inventor name

Mendham, NJ, United States of America

Charles Michael Cook

USPTO Granted Patents = 14 (Patent Applications = 1)

Average Co-Inventor Count = 5.2

ph-index = 7

Forward Citations = 302(Granted Patents)

Company Filing History:

Praecis Pharmaceuticals, Inc.

Provid Pharmaceuticals Inc.

4. 1 out of 15,475

University of California

5. 1 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

where one patent can have more than one assignee

Years Active: 2003-2014

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8765802 - Kinase inhibitors, compositions thereof, and methods of use therewith (2014-07-01),

2. 8598312 - Inhibitors of antigen presentation by MHC class II molecules (2013-12-03),

3. 8222215 - Methods for the use of inhibitors of antigen presentation by MHC class II molecules (2012-07-17),

4. 7439231 - Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof (2008-10-21),

5. 7432342 - Kinase anchor protein muteins, peptides thereof and related documents (2008-10-07),

6. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),

7. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),

8. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),

9. 7157420 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-01-02),

10. 7105482 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2006-09-12),

11. 7084108 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2006-08-01),

12. 7037890 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2006-05-02),

13. 6919307 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2005-07-19),

14. 6548477 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2003-04-15),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…